Omada Health president uses 6,180 shares for equity costs

Omada Health’s president reported a small share disposition related to option exercise price or tax obligations, with over three hundred thousand shares still held directly.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that its President, Wei-Li Shao, disposed of 6,180 shares of common stock on September 1, 2026 as shares were delivered or withheld for payment of exercise price or tax liability. After this transaction, he directly held 301,192 shares of Omada Health common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 6,180 shares

Exercise Price or Tax Liability 1 txn

Insider Shao Wei-Li

Role President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	6,180	$22.84	$141K

Holdings After Transaction: Common Stock — 301,192 shares (Direct)

Key Figures

Shares delivered or withheld: 6,180 shares Per-share value for transaction: $22.84 per share Post-transaction direct holdings: 301,192 shares +2 more

5 metrics

Shares delivered or withheld 6,180 shares Common stock disposed of on September 1, 2026 to pay exercise price or tax liability

Per-share value for transaction $22.84 per share Value used for the September 1, 2026 disposition related to exercise price or tax liability

Post-transaction direct holdings 301,192 shares Common stock directly owned by the President after the reported transaction

Reporting person role President Officer title of Wei-Li Shao at Omada Health, Inc.

Transactions for payment of exercise price or tax liability 1 transaction Number of such transactions reported in this Form 4

Key Terms

Payment of exercise price or tax liability

1 terms

Payment of exercise price or tax liability financial

"transaction described as payment of exercise price or tax liability by delivering or withholding securities"

FAQ

What insider transaction did Omada Health (OMDA) report for its president?

The President of Omada Health, Wei-Li Shao, reported a disposition of 6,180 shares of common stock on September 1, 2026, with shares delivered or withheld to cover exercise price or tax liability rather than an open-market sale.

At what price were the Omada Health (OMDA) shares valued in this Form 4 transaction?

The 6,180 shares of Omada Health common stock in the reported transaction were valued at $22.84 per share for the purpose of calculating the payment of exercise price or tax liability by delivering or withholding securities.

How many Omada Health (OMDA) shares does the president hold after this Form 4 event?

Following the September 1, 2026 transaction, Omada Health’s President, Wei-Li Shao, directly held 301,192 shares of the company’s common stock, as reported in the Form 4 filing.

Was the Omada Health (OMDA) insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the transaction by Omada Health’s President on September 1, 2026 was not reported as being made under a Rule 10b5-1 trading plan.

What is the nature of the Omada Health (OMDA) insider’s ownership in this filing?

The Form 4 reports that the President’s holdings of 301,192 shares of Omada Health common stock after the transaction are held as direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 06:34 PM Accepted by SEC EDGAR 09/03/2026 - 06:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		F		6,180	D	$22.84	301,192	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)